Colgate-Palmolive (India) shares fall over 2% after Investor Day 2026; Goldman Sachs Neutral, Motilal Oswal and Nuvama maintain Buy
Key Takeaways
- •Colgate-Palmolive (India) shares fell more than 2% after its Investor Day 2026, at which management presented its strategy and outlook to shareholders and analysts.
- •Goldman Sachs retained a Neutral rating on the stock, while Motilal Oswal and Nuvama maintained Buy ratings following the event.
- •Domestic brokerages cited volume recovery, premiumisation and expansion beyond the core oral care business as the main growth drivers for the company.
- •Higher brand investment is intended to build demand and defend market share but adds to the near-term cost base.
- •The report was published on 18 August 2026, and the stock trades on the BSE and the National Stock Exchange, with upcoming quarterly results as the next reference point.

Shares of Colgate-Palmolive (India) slipped more than 2% following the company's Investor Day 2026, as investors weighed plans for higher brand investments against the company's long-term growth and profitability strategy.
Colgate-Palmolive (India) is the listed Indian arm of US consumer goods major Colgate-Palmolive Company and one of the country's leading fast-moving consumer goods (FMCG) companies, best known for its oral care portfolio spanning toothpaste, toothpowder, toothbrushes and mouthwash, alongside personal care products under the Palmolive brand. The company has long been the market leader in India's toothpaste category, a position built on continuous advertising and brand investment. Investor Day is an event at which company management presents its strategy and outlook to shareholders and analysts.
Brokerage views following the event diverged:
- Goldman Sachs retained a Neutral view on the stock.
- Motilal Oswal maintained a Buy rating.
- Nuvama also maintained a Buy rating.
The domestic brokerages cited volume recovery, premiumisation and category expansion as the key growth drivers for the company, according to the Economic Times Markets report. Premiumisation — shifting the sales mix towards higher-priced, value-added products — has been a broad strategy across India's FMCG sector as companies look to grow beyond volume-led expansion, while category expansion for Colgate-Palmolive (India) points to pushing further beyond its core oral care business.
Higher brand investment is a standard lever for FMCG companies to build demand and defend market share, though it adds to the near-term cost base. For a stock listed on the BSE and the National Stock Exchange, the reference points from here are the company's upcoming quarterly results and management commentary on how the planned brand spending translates into volume growth and profitability.
The report was published on 18 August 2026. Further details, including Colgate management commentary from the event, were carried in the original article on ETMarkets.